These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 30005281)
21. Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice. Souza LC; Jesse CR; de Gomes MG; Del Fabbro L; Goes ATR; Donato F; Boeira SP Neurochem Res; 2017 Oct; 42(10):2982-2995. PubMed ID: 28631232 [TBL] [Abstract][Full Text] [Related]
22. Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase. Souza LC; Jesse CR; de Gomes MG; Viana CE; Mattos E; Silva NC; Boeira SP Neurotox Res; 2017 May; 31(4):464-477. PubMed ID: 28155213 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of the BET family reduces its new target gene IDO1 expression and the production of L-kynurenine. Tian CQ; Chen L; Chen HD; Huan XJ; Hu JP; Shen JK; Xiong B; Wang YQ; Miao ZH Cell Death Dis; 2019 Jul; 10(8):557. PubMed ID: 31324754 [TBL] [Abstract][Full Text] [Related]
26. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. Li Y; Hu N; Yang D; Oxenkrug G; Yang Q FEBS J; 2017 Mar; 284(6):948-966. PubMed ID: 28118532 [TBL] [Abstract][Full Text] [Related]
27. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation. Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467 [TBL] [Abstract][Full Text] [Related]
28. The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy. Ogiso H; Ito H; Kanbe A; Ando T; Hara A; Shimizu M; Moriwaki H; Seishima M Dig Dis Sci; 2017 Sep; 62(9):2386-2396. PubMed ID: 28639129 [TBL] [Abstract][Full Text] [Related]
29. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease. Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539 [TBL] [Abstract][Full Text] [Related]
30. Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model. Wu X; Chen B; Di Z; Jiang S; Xu H; Shi M; Hu R; Sun S; Song Z; Liu J; Ma R; Guo Q BMC Neurosci; 2022 Nov; 23(1):62. PubMed ID: 36357867 [TBL] [Abstract][Full Text] [Related]
32. Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress. Koo YS; Kim H; Park JH; Kim MJ; Shin YI; Choi BT; Lee SY; Shin HK Oxid Med Cell Longev; 2018; 2018():2413841. PubMed ID: 30693061 [TBL] [Abstract][Full Text] [Related]
33. Detection of the role of intestinal flora and tryptophan metabolism involved in antidepressant-like actions of crocetin based on a multi-omics approach. Lin S; Li Q; Xu Z; Chen Z; Tao Y; Tong Y; Wang T; Chen S; Wang P Psychopharmacology (Berl); 2022 Nov; 239(11):3657-3677. PubMed ID: 36169685 [TBL] [Abstract][Full Text] [Related]
34. Attenuation of oxidative stress and neurotoxicity involved in the antidepressant-like effect of the MK-801(dizocilpine) in Bacillus Calmette-Guerin-induced depression in mice. Rana P; Bagewadi H; Banerjee BD; Bhattacharya SK; Mediratta PK J Basic Clin Physiol Pharmacol; 2020 Apr; 31(4):. PubMed ID: 32324160 [TBL] [Abstract][Full Text] [Related]
35. Role of indoleamine 2,3-dioxygenase in health and disease. Yeung AW; Terentis AC; King NJ; Thomas SR Clin Sci (Lond); 2015 Oct; 129(7):601-72. PubMed ID: 26186743 [TBL] [Abstract][Full Text] [Related]
36. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis. Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138 [TBL] [Abstract][Full Text] [Related]
37. Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function. Too LK; Li KM; Suarna C; Maghzal GJ; Stocker R; McGregor IS; Hunt NH Behav Brain Res; 2016 Oct; 312():102-17. PubMed ID: 27316339 [TBL] [Abstract][Full Text] [Related]
38. IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis. Bishnupuri KS; Alvarado DM; Khouri AN; Shabsovich M; Chen B; Dieckgraefe BK; Ciorba MA Cancer Res; 2019 Mar; 79(6):1138-1150. PubMed ID: 30679179 [TBL] [Abstract][Full Text] [Related]
39. Kynurenines in cognitive functions: their possible role in depression. Plangar I; Majlath Z; Vecsei L Neuropsychopharmacol Hung; 2012 Dec; 14(4):239-44. PubMed ID: 23269210 [TBL] [Abstract][Full Text] [Related]
40. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease. Boros FA; Klivényi P; Toldi J; Vécsei L Expert Opin Ther Targets; 2019 Jan; 23(1):39-51. PubMed ID: 30449219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]